| Financial Year |
March 31 2023 |
| Monetary Funds |
2,578,087,665.14 |
| Held-for-trading Financial Assets |
128,316,940.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
587,075,533.39 |
| Advances to Suppliers |
606,275,855.42 |
| Other Receivables |
325,023,822.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,619,950,849.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
142,975,778.43 |
| Total Current Assets |
5,987,706,444.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,001,779,782.94 |
| Investment Properties |
14,291,353.30 |
| Fixed Assetes |
1,652,521,473.91 |
| Under-construction Projects |
175,649,497.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,335,651,695.86 |
| R&D expenses |
258,467,224.76 |
| Goodwill |
1,548,773,891.29 |
| Long-Term Deferred and Prepaid Expenses |
37,277,251.96 |
| Deferred Income Tax Assets |
51,735.79 |
| Other Non-Current Assets |
9,395,600.00 |
| Sub-Total of Non-Current Assets |
8,488,131,362.41 |
| Total Assets |
14,475,837,806.55 |
| Short-Term Loans |
4,461,755,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
306,353,796.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
107,024,870.17 |
| Taxes Payable |
16,646,702.45 |
| Interest Payable |
-- |
| Dividend Payable |
69,933,687.97 |
| Other payables |
401,462,911.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,102,865,524.29 |
| Other Current Liabilities |
231,465,451.61 |
| Sub-Total of Current Liabilities |
7,710,935,986.75 |
| Long-term Loans |
196,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
87,601,736.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
10,011,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
684,402,223.82 |
| Total Liabilities |
8,395,338,210.57 |
| Paid-In Capital(Or Share Stock) |
1,316,970,298.00 |
| Capital Surplus |
3,041,670,886.42 |
| Surplus Reserve |
183,037,739.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,613,954,396.73 |
| Minority Stockholder's Interest |
783,733,351.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,296,766,244.41 |
| Owner's Equity（Stockholder's Equity） |
6,080,499,595.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,475,837,806.55 |
